Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBYI | PUMA BIOTECHNOLOGY INC | $171.25M | $3.45 | $7.00 | 102.90% | Buy | 1 | 0.18% | -24.90% | 27.09% | 13.41% | |||
EXEL | EXELIXIS INC | $12.43B | $45.58 | $45.13 | -0.98% | Buy | 15 | 10.11% | 16.30% | 60.91% | 45.75% | |||
AUPH | AURINIA PHARMACEUTICALS INC | $1.22B | $9.04 | N/A | N/A | N/A | N/A | 17.88% | 64.08% | 76.77% | 53.25% | |||
RIGL | RIGEL PHARMACEUTICALS INC | $345.83M | $19.35 | $39.75 | 105.43% | Buy | 4 | 7.67% | -8.94% | 238.72% | 25.19% | |||
ZVRA | ZEVRA THERAPEUTICS INC | $699.35M | $12.79 | $23.33 | 82.43% | Strong Buy | 6 | 72.28% | N/A | 329.23% | 78.20% | |||
HALO | HALOZYME THERAPEUTICS INC | $7.10B | $57.65 | $66.40 | 15.18% | Buy | 5 | 14.07% | 15.64% | 224.59% | 49.31% | |||
PTCT | PTC THERAPEUTICS INC | $3.92B | $49.46 | $64.75 | 30.91% | Buy | 12 | -21.64% | N/A | -124.59% | 8.72% | |||
NAGE | NIAGEN BIOSCIENCE INC | $886.95M | $11.26 | $14.53 | 29.00% | Strong Buy | 4 | 18.38% | 8.02% | 40.56% | 27.60% | |||
CRMD | CORMEDIX INC | $770.49M | $11.36 | $17.00 | 49.65% | Buy | 6 | 54.69% | 106.40% | 159.69% | 122.65% | |||
CPRX | CATALYST PHARMACEUTICALS INC | $2.64B | $21.62 | $33.33 | 54.18% | Strong Buy | 3 | 10.42% | 16.72% | 40.85% | 35.70% | |||
BMRN | BIOMARIN PHARMACEUTICAL INC | $11.17B | $58.23 | $97.50 | 67.44% | Strong Buy | 10 | 9.17% | 24.46% | N/A | N/A | |||
INCY | INCYTE CORP | $13.55B | $69.98 | $73.64 | 5.22% | Hold | 11 | 8.67% | 196.45% | 45.13% | 28.79% | |||
BCRX | BIOCRYST PHARMACEUTICALS INC | $1.87B | $8.96 | $17.22 | 92.21% | Strong Buy | 9 | 14.54% | N/A | -47.38% | 44.61% | |||
AKBA | AKEBIA THERAPEUTICS INC | $1.04B | $3.97 | $6.90 | 73.80% | Strong Buy | 5 | 19.75% | N/A | 456.76% | 36.20% | |||
CSBR | CHAMPIONS ONCOLOGY INC | $110.20M | $7.97 | $12.00 | 50.56% | Buy | 1 | N/A | N/A | N/A | N/A | |||
HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.99B | $34.71 | $55.17 | 58.94% | Strong Buy | 6 | 16.44% | 24.63% | 52.24% | 35.66% | |||
KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $2.10B | $28.80 | $40.25 | 39.76% | Strong Buy | 4 | 20.89% | N/A | 34.21% | 26.12% | |||
ALNY | ALNYLAM PHARMACEUTICALS INC | $41.17B | $315.75 | $359.81 | 13.96% | Strong Buy | 16 | 29.24% | N/A | 1,465.01% | 40.13% | |||
IMCR | IMMUNOCORE HOLDINGS PLC | $1.77B | $35.30 | $62.50 | 77.05% | Buy | 6 | 14.31% | N/A | 48.64% | 17.91% | |||
BDTX | BLACK DIAMOND THERAPEUTICS INC | $167.18M | $2.94 | $12.67 | 330.85% | Strong Buy | 3 | -47.10% | N/A | -24.24% | -19.46% | |||
INVA | INNOVIVA INC | $1.23B | $19.58 | $40.33 | 105.99% | Strong Buy | 3 | N/A | N/A | 17.86% | 9.21% | |||
NVO | NOVO NORDISK A S | $307.82B | $68.94 | $64.00 | -7.17% | Hold | 1 | 10.53% | 13.16% | 121.91% | 34.53% | |||
PLX | PROTALIX BIOTHERAPEUTICS INC | $113.04M | $1.42 | $15.00 | 956.34% | Buy | 1 | N/A | N/A | N/A | N/A | |||
FENC | FENNEC PHARMACEUTICALS INC | $242.77M | $8.79 | $13.00 | 47.90% | Buy | 2 | 51.51% | N/A | -1,075.63% | 136.30% | |||
ARWR | ARROWHEAD PHARMACEUTICALS INC | $2.57B | $18.61 | $47.40 | 154.70% | Buy | 5 | -24.26% | N/A | -61.37% | -26.65% | |||
XLO | XILIO THERAPEUTICS INC | $38.32M | $0.74 | N/A | N/A | N/A | N/A | 75.45% | N/A | -135.51% | -13.98% | |||
HRTX | HERON THERAPEUTICS INC | $323.43M | $2.12 | $5.00 | 135.85% | Buy | 2 | 12.70% | N/A | -214.48% | 25.89% | |||
MDXG | MIMEDX GROUP INC | $1.00B | $6.80 | $13.00 | 91.18% | Strong Buy | 1 | 11.95% | 35.86% | N/A | N/A | |||
IMAB | I-MAB | $174.71M | $2.14 | $6.33 | 195.93% | Buy | 3 | N/A | N/A | -71.91% | -68.27% | |||
ONC | BEONE MEDICINES LTD | $27.24B | $252.14 | $325.56 | 29.12% | Strong Buy | 9 | 20.12% | N/A | 535.74% | 320.95% | |||
XOMA | XOMA ROYALTY CORP | $332.20M | $27.76 | $69.50 | 150.36% | Strong Buy | 2 | 16.88% | N/A | 55.01% | 21.88% | |||
ZYME | ZYMEWORKS INC | $930.27M | $13.35 | $16.00 | 19.85% | Buy | 2 | 26.34% | N/A | -7.51% | -5.73% | |||
KROS | KEROS THERAPEUTICS INC | $591.77M | $14.57 | $20.63 | 41.56% | Buy | 8 | -46.71% | N/A | -21.05% | -19.55% | |||
TBPH | THERAVANCE BIOPHARMA INC | $573.52M | $11.47 | $21.33 | 85.99% | Strong Buy | 3 | 19.39% | N/A | 16.72% | 8.08% | |||
RPRX | ROYALTY PHARMA PLC | $20.38B | $36.24 | $54.00 | 49.01% | Strong Buy | 1 | 20.41% | 43.30% | 31.50% | 17.51% | |||
ZLAB | ZAI LAB LTD | $3.72B | $34.28 | $54.28 | 58.33% | Buy | 4 | 38.12% | N/A | 56.19% | 38.83% | |||
STOK | STOKE THERAPEUTICS INC | $658.44M | $12.06 | $27.00 | 123.88% | Strong Buy | 3 | -53.76% | N/A | -26.20% | -22.54% | |||
GMAB | GENMAB A | $14.21B | $21.46 | $36.67 | 70.86% | Strong Buy | 3 | 16.90% | 14.38% | 4.59% | 3.69% | |||
ARGX | ARGENX SE | $34.10B | $561.28 | $766.63 | 36.59% | Strong Buy | 8 | 976.30% | 25.02% | 39.84% | 35.32% | |||
ATRA | ATARA BIOTHERAPEUTICS INC | $55.44M | $9.30 | $17.00 | 82.80% | Strong Buy | 1 | -40.77% | N/A | N/A | N/A | |||
MNKD | MANNKIND CORP | $1.22B | $4.03 | N/A | N/A | N/A | N/A | 13.97% | 40.10% | -212.58% | 30.38% | |||
VCYT | VERACYTE INC | $2.09B | $26.65 | $42.00 | 57.60% | Strong Buy | 5 | 8.13% | 49.36% | 7.47% | 6.79% | |||
XERS | XERIS BIOPHARMA HOLDINGS INC | $871.24M | $5.44 | $6.25 | 14.89% | Buy | 6 | 18.67% | N/A | -264.43% | 29.45% | |||
VRTX | VERTEX PHARMACEUTICALS INC | $121.30B | $472.35 | $500.38 | 5.93% | Buy | 16 | 8.45% | N/A | N/A | N/A | |||
ARQT | ARCUTIS BIOTHERAPEUTICS INC | $1.90B | $15.90 | $18.80 | 18.24% | Buy | 5 | 34.62% | N/A | 111.97% | 46.42% | |||
UTHR | UNITED THERAPEUTICS CORP | $13.43B | $297.68 | $357.43 | 20.07% | Buy | 7 | 5.45% | -0.01% | 22.01% | 19.35% | |||
TECH | BIO-TECHNE CORP | $8.25B | $52.62 | $70.00 | 33.03% | Buy | 11 | 7.55% | 56.97% | 15.89% | 12.12% | |||
TGTX | TG THERAPEUTICS INC | $6.18B | $38.92 | $55.00 | 41.32% | Buy | 1 | 37.60% | 104.81% | 225.80% | 81.59% | |||
ACAD | ACADIA PHARMACEUTICALS INC | $3.66B | $21.89 | $28.19 | 28.77% | Buy | 16 | 9.71% | 0.37% | 45.84% | 30.98% | |||
ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | $1.75B | $11.55 | $11.80 | 2.16% | Buy | 5 | 19.16% | N/A | -26.59% | -9.91% | |||
MDGL | MADRIGAL PHARMACEUTICALS INC | $7.10B | $319.87 | $442.50 | 38.34% | Strong Buy | 6 | 76.59% | N/A | 120.58% | 85.98% | |||
WHWK | WHITEHAWK THERAPEUTICS INC | $96.57M | $2.05 | N/A | N/A | N/A | N/A | 5.05% | N/A | -12.11% | -11.48% | |||
CORT | CORCEPT THERAPEUTICS INC | $7.72B | $72.77 | $142.00 | 95.14% | Strong Buy | 4 | 31.13% | 52.86% | 126.10% | 101.79% | |||
LGND | LIGAND PHARMACEUTICALS INC | $2.45B | $126.92 | $144.00 | 13.46% | Strong Buy | 2 | 14.46% | N/A | 12.64% | 11.10% | |||
CTMX | CYTOMX THERAPEUTICS INC | $192.68M | $2.39 | $5.00 | 109.21% | Strong Buy | 2 | -25.75% | N/A | -201.16% | -51.16% | |||
NVAX | NOVAVAX INC | $1.13B | $6.97 | $6.50 | -6.74% | Strong Sell | 2 | -40.27% | N/A | -131.69% | 7.70% | |||
MIRM | MIRUM PHARMACEUTICALS INC | $2.64B | $53.28 | $70.60 | 32.51% | Buy | 5 | 18.71% | N/A | 29.52% | 9.98% | |||
CADL | CANDEL THERAPEUTICS INC | $322.16M | $6.43 | $21.40 | 232.81% | Strong Buy | 5 | N/A | N/A | 4.03% | 3.13% | |||
AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $3.15B | $36.20 | N/A | N/A | N/A | N/A | 28.06% | N/A | -356.54% | -36.12% | |||
SPRO | SPERO THERAPEUTICS INC | $147.60M | $2.64 | $5.00 | 89.39% | Buy | 1 | 34.58% | N/A | -190.15% | -82.74% | |||
SEER | SEER INC | $125.39M | $2.13 | N/A | N/A | N/A | N/A | 31.96% | N/A | N/A | N/A | |||
IPSC | CENTURY THERAPEUTICS INC | $51.70M | $0.60 | $3.75 | 525.00% | Strong Buy | 4 | N/A | N/A | -35.12% | -26.75% | |||
RGNX | REGENXBIO INC | $436.40M | $8.70 | $31.00 | 256.32% | Buy | 6 | 19.77% | N/A | -29.27% | -16.35% | |||
ACOG | ALPHA COGNITION INC | $168.69M | $10.53 | $20.00 | 89.93% | Buy | 1 | 202.84% | N/A | 1,364.03% | 1,145.25% | |||
SEPN | SEPTERNA INC | $535.15M | $12.01 | $23.00 | 91.51% | Buy | 3 | N/A | N/A | -36.85% | -33.98% | |||
FHTX | FOGHORN THERAPEUTICS INC | $327.76M | $5.88 | $11.25 | 91.33% | Strong Buy | 4 | 21.07% | N/A | N/A | -13.50% | |||
MESO | MESOBLAST LTD | $1.29B | $11.17 | $24.00 | 114.86% | Strong Buy | 1 | 347.80% | N/A | N/A | N/A | |||
TVTX | TRAVERE THERAPEUTICS INC | $1.50B | $16.91 | $35.55 | 110.20% | Strong Buy | 11 | 36.52% | N/A | 511.89% | 30.62% | |||
MCRB | SERES THERAPEUTICS INC | $129.68M | $14.85 | $10.50 | -29.29% | Sell | 2 | N/A | N/A | 1,273.57% | 391.46% | |||
GLUE | MONTE ROSA THERAPEUTICS INC | $323.54M | $5.26 | $13.50 | 156.65% | Buy | 2 | -8.58% | N/A | -21.91% | -15.33% | |||
TSHA | TAYSHA GENE THERAPIES INC | $566.71M | $2.64 | $8.17 | 209.36% | Strong Buy | 6 | 6.25% | N/A | -91.62% | -36.46% | |||
TARS | TARSUS PHARMACEUTICALS INC | $1.74B | $41.53 | $67.14 | 61.67% | Strong Buy | 7 | 44.16% | N/A | 5.40% | 3.69% | |||
ACIU | AC IMMUNE SA | $208.85M | $2.08 | $12.00 | 476.92% | Buy | 1 | 48.91% | N/A | 56.02% | 25.16% | |||
AGEN | AGENUS INC | $187.26M | $6.83 | $15.50 | 126.94% | Buy | 2 | 4.37% | N/A | N/A | -26.36% | |||
ASND | ASCENDIS PHARMA A | $10.61B | $174.89 | $232.27 | 32.81% | Strong Buy | 11 | 62.89% | N/A | -369.35% | 66.05% | |||
KYMR | KYMERA THERAPEUTICS INC | $2.92B | $44.90 | $59.09 | 31.61% | Strong Buy | 11 | -3.79% | N/A | -33.38% | -28.58% | |||
FOLD | AMICUS THERAPEUTICS INC | $1.92B | $6.24 | $17.25 | 176.44% | Strong Buy | 4 | 17.42% | N/A | 74.77% | 18.32% | |||
NTRB | NUTRIBAND INC | $89.68M | $8.04 | $13.00 | 61.69% | Buy | 1 | 321.68% | N/A | 799.94% | 663.57% | |||
FTRE | FORTREA HOLDINGS INC | $450.90M | $5.01 | $5.50 | 9.78% | Sell | 4 | -0.95% | N/A | 10.90% | 3.00% | |||
GYRE | GYRE THERAPEUTICS INC | $713.50M | $7.61 | N/A | N/A | N/A | N/A | 52.00% | 179.85% | 399.13% | 209.49% | |||
KRYS | KRYSTAL BIOTECH INC | $4.35B | $150.41 | $203.63 | 35.38% | Strong Buy | 8 | 36.65% | 39.87% | 36.89% | 33.81% | |||
ATAI | ATAI LIFE SCIENCES NV | $544.92M | $2.72 | $11.00 | 304.41% | Strong Buy | 2 | 32.06% | N/A | -44.14% | -34.28% | |||
TLX | TELIX PHARMACEUTICALS LTD | $5.21B | $15.57 | $22.33 | 43.44% | Strong Buy | 3 | 37.80% | N/A | N/A | N/A | |||
FULC | FULCRUM THERAPEUTICS INC | $426.44M | $7.90 | $8.75 | 10.76% | Strong Buy | 4 | 25.04% | N/A | -26.22% | -24.69% | |||
HLVX | HILLEVAX INC | $108.81M | $2.17 | $2.00 | -7.83% | Hold | 1 | N/A | N/A | -17.11% | -14.44% | |||
AEON | AEON BIOPHARMA INC | $9.44M | $0.84 | N/A | N/A | N/A | N/A | N/A | N/A | -1,653.29% | 1,356.64% | |||
VRCA | VERRICA PHARMACEUTICALS INC | $75.38M | $0.82 | N/A | N/A | N/A | N/A | 90.91% | N/A | -54.77% | 24.12% | |||
ANIX | ANIXA BIOSCIENCES INC | $103.08M | $3.20 | $9.00 | 181.25% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
LEGN | LEGEND BIOTECH CORP | $7.26B | $39.44 | $70.00 | 77.48% | Strong Buy | 6 | 43.88% | N/A | 157.82% | 99.42% | |||
ARVN | ARVINAS INC | $574.44M | $7.87 | $18.71 | 137.75% | Buy | 19 | -36.44% | N/A | -16.03% | -10.57% | |||
CNTA | CENTESSA PHARMACEUTICALS PLC | $2.02B | $15.13 | $31.60 | 108.86% | Strong Buy | 5 | 116.50% | N/A | -45.78% | -33.50% | |||
ERAS | ERASCA INC | $413.60M | $1.46 | $4.50 | 208.22% | Strong Buy | 4 | N/A | N/A | -34.39% | -29.16% | |||
ASMB | ASSEMBLY BIOSCIENCES INC | $143.89M | $18.84 | $31.00 | 64.54% | Strong Buy | 1 | N/A | N/A | -346.79% | -95.03% | |||
LCTX | LINEAGE CELL THERAPEUTICS INC | $244.34M | $1.07 | $4.67 | 336.17% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
SLS | SELLAS LIFE SCIENCES GROUP INC | $197.56M | $1.98 | N/A | N/A | N/A | N/A | N/A | N/A | -140.18% | -111.32% | |||
MBIO | MUSTANG BIO INC | $10.59M | $2.42 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
CDTX | CIDARA THERAPEUTICS INC | $717.49M | $55.32 | $53.00 | -4.19% | Strong Buy | 8 | 202.85% | N/A | -72.13% | -53.31% | |||
ABVC | ABVC BIOPHARMA INC | $58.87M | $3.51 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
ADCT | ADC THERAPEUTICS SA | $332.25M | $3.35 | $7.80 | 132.84% | Strong Buy | 5 | 21.13% | N/A | -1.67% | 1.46% | |||
TVRD | TVARDI THERAPEUTICS INC | $279.24M | $29.83 | $59.20 | 98.46% | Strong Buy | 5 | 42.11% | N/A | N/A | -212.23% |